AU2002368314A1 - Iminosugar derivatives as glucosidase inhibitors - Google Patents

Iminosugar derivatives as glucosidase inhibitors

Info

Publication number
AU2002368314A1
AU2002368314A1 AU2002368314A AU2002368314A AU2002368314A1 AU 2002368314 A1 AU2002368314 A1 AU 2002368314A1 AU 2002368314 A AU2002368314 A AU 2002368314A AU 2002368314 A AU2002368314 A AU 2002368314A AU 2002368314 A1 AU2002368314 A1 AU 2002368314A1
Authority
AU
Australia
Prior art keywords
glucosidase inhibitors
iminosugar derivatives
iminosugar
derivatives
glucosidase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002368314A
Inventor
Jasbir Singh Arora
Jang Bahadur Gupta
Nidhi Gupta
Upendra Kumar Pandit
Mohammad Salman
Geeta Sharma
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ranbaxy Laboratories Ltd
Original Assignee
Ranbaxy Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Ltd filed Critical Ranbaxy Laboratories Ltd
Publication of AU2002368314A1 publication Critical patent/AU2002368314A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H7/00—Compounds containing non-saccharide radicals linked to saccharide radicals by a carbon-to-carbon bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002368314A 2002-10-29 2002-10-29 Iminosugar derivatives as glucosidase inhibitors Abandoned AU2002368314A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/IB2002/004496 WO2004039373A1 (en) 2002-10-29 2002-10-29 Iminosugar derivatives as glucosidase inhibitors

Publications (1)

Publication Number Publication Date
AU2002368314A1 true AU2002368314A1 (en) 2004-05-25

Family

ID=32259847

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002368314A Abandoned AU2002368314A1 (en) 2002-10-29 2002-10-29 Iminosugar derivatives as glucosidase inhibitors

Country Status (3)

Country Link
EP (1) EP1575587A1 (en)
AU (1) AU2002368314A1 (en)
WO (1) WO2004039373A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2391218B1 (en) * 2009-01-28 2020-03-18 Smartcells, Inc. Conjugate based systems for controlled drug delivery
CN103373955B (en) * 2012-04-23 2016-04-06 北京大学 Multivalence Azasugar and synthetic method thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2922760A1 (en) * 1979-06-05 1980-12-11 Bayer Ag NEW DERIVATIVES OF 3,4,5-TRIHYDROXYPIPERIDINE, METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS A MEDICINAL PRODUCT AND IN ANIMAL FOOD
JPS56108767A (en) * 1980-01-28 1981-08-28 Nippon Shinyaku Co Ltd Bismoranoline derivative
JPS6055078B2 (en) * 1980-12-01 1985-12-03 日本新薬株式会社 Derivatives of moranoline

Also Published As

Publication number Publication date
WO2004039373A1 (en) 2004-05-13
EP1575587A1 (en) 2005-09-21

Similar Documents

Publication Publication Date Title
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
AU2003249532A1 (en) 4-hydroxyquinoline derivatives as matrix metalloproteinase inhibitors
AU2003260345A1 (en) 2-phenylpyridin-4-yl derivatives as alk5 inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
HK1071360A1 (en) 2-hydroxy-3-heteroarylindole derivatives as gsk3 inhibitors
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003255492A1 (en) Heterocyclic derivatives
AU2003301863A1 (en) SULFONYLAMINOVALEROLAC TAMS AND DERIVATIVES THEREOF AS FACTOR Xa INHIBITORS
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2003303483A1 (en) Ccr8 inhibitors
AU2003293356A1 (en) Dihydropyridinone derivatives as hne inhibitors
AU2003249531A1 (en) Azaisoquinoline derivatives as matrix metalloproteinase inhibitors
IL165887A0 (en) Novel tetrahydropyridine derivatives as renin inhibitors
AU2003302238A1 (en) 2-(2-hydroxybiphenyl-3-yl)-1h-benzoimidazole-5-carboxamidine derivatives as factor viia inhibitors
AU2003250482A1 (en) Phthalimide derivatives as matrix metalloproteinase inhibitors
AU2003299883A1 (en) Ccr8 inhibitors
AU2003202116A1 (en) Nicotinamide derivatives useful as pde4 inhibitors
AU2003250469A1 (en) Isoquinoline derivatives as matrix metalloproteinase inhibitors
AU2003250475A1 (en) 5,6-fused 3,4-dihydropyrimidine-2-one derivatives as matrix metalloproteinase inhibitors
AU2003249683A1 (en) Nf-:b inhibitors
AU2003232848A1 (en) Phenylaminopyrimidines and their use as rho-kinase inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase